Back to Treatments

Treatment

Mavacamten

1
Conditions
31
Trials
2,000
Participants
65%
Average Safety

Condition Evidence

Hypertrophic Cardiomyopathy

31 trials · 2,000 participants

85% effectiveness · 65% safety
Mavacamten | DFDA